Loading clinical trials...

Surgical Removal of Idiopathic Epiretinal Membrane With and Without the Assistance of Indocyanine Green. | Clinical Trials | Clareo Health

COMPLETEDNA

Surgical Removal of Idiopathic Epiretinal Membrane With and Without the Assistance of Indocyanine Green.

Surgical Removal of Idiopathic Epiretinal Membrane With and Without the Assistance of Indocyanine Green: a Randomised Controlled Clinical Trial

NCT00376857•University of Regensburg

View on ClinicalTrials.gov

Summary

It was the aim of the present study to prospectively compare the functional and morphological outcome of idiopathic epiretinal membrane surgery with and without the assistance of Indocyanine green (ICG). The main outcome measure was improvement of best-corrected visual acuity (BCVA). This was treated as an open question and we had no hypothesis which of the two therapies was superior.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Patients with IEM and cataract or posterior chamber intraocular lens pseudophakia complaining of loss of visual acuity and metamorphopsia during the past six months.

Exclusion Criteria

•Other retinal disease, non-idiopathic epiretinal membrane, glaucoma or history of retinal detachment.

Locations (1)

Dept. of Ophthalmology, University of Regensburg

Regensburg, Germany

Key Dates

Last Updated

September 15, 2006

Enrollment

Estimated participants

Conditions

Idiopathic Epiretinal Membrane, Cataract

Interventions

Surgery with and without the aid of Indocyanine Green (ICG)

DRUG